World Cell Expansion Market Analysis 2019 by Geographical (North America., Europe, Asia, ROW)

The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The global cell expansion market is categorized on the basis of product, cell type, application, end user, and geography. The human cell expansion segment is expected to register the highest growth rate in the cell expansion market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell research and the increasing usage of stem cell for treating various disorders. Also, the market of regenerative medicines is expected to grow at highest CAGR in the cell expansion application market. This growth is attributed to the increasing government investments and technological advancements in this segment.

The Cell Expansion Market report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Complete report available @ http://www.reportsnreports.com/reports/313419-cell-expansion-market-by-product-reagent-media-serum-bioreactors-centrifuge-cell-type-human-animal-application-stem-cell-research-regenerative-medicine-clinical-diagnostics-end-user-hospital-biotechnology-cell-bank-forecast-to-2019.html .

Major factors contributing to growth of the cell expansion market include the increasing research activities, technological advancements, high prevalence of chronic diseases, and rising investments by companies are likely to propel the growth of this market. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in April 2013, Scottish government granted $13.5 million to the College of Life Sciences at the University of Dundee (Scotland) for development of advanced stem cell technology. The relatively untapped markets of the Asian region and advent of 3D technology in cell expansion have opened an array of opportunities for the cell expansion market. However, high cost of instruments and ethical concerns are expected to restrain the growth of this market.

The Asian region and cell expansion consumables are expected to serve as new revenue pockets for the cell expansion market in the coming five years.

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by the industry players over the last three years. In addition, the company profiles comprise the basic views on the key players in the cell expansion market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=313419 .

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Cell Expansion Market, By Product

8 Cell Expansion Market, By Cell Type

9 Cell Expansion Market, By Application

10 Cell Expansion Market, By End User

11 Cell Expansion Market, By Geography

12 Competitive Landscape

13 Company Profiles

13.1 Beckman Coulter (Subsidiary of Danaher Corporation)

13.2 Becton Dickinson and Company

13.3 Corning Incorporated

13.4 Ge Healthcare (A Fully Owned Subsidiary of General Electric Company)

13.5 Merck Millipore (A Segment of Merck Kgaa)

13.6 Miltenyi Biotec

13.7 Sigma-Aldrich Corporation

13.8 Stemcell Technologies

13.9 Terumo BCT (A Subsidiary of Terumo Corporation)

13.10 Thermo Fisher Scientific, Inc.

Inquire For Discount (Single User Report Price US $4650) @ http://www.reportsnreports.com/contacts/Discount.aspx?name=313419 .